A new WHO guideline on GLP-1s and recent efforts to reduce the drugs’ costs now and going forward are unlikely to change US obesity practice — but other actions might.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/who-guidance-glp-1-price-curbs-unlikely-change-practice-2025a1000ybf?src=rss
Author :
Publish date : 2025-12-08 15:33:00
Copyright for syndicated content belongs to the linked Source.
